title: [Pharmacological and clinical profile of ramosetron hydrochloride (Irribow), a novel therapeutic agent for irritable bowel syndrome with diarrhea].
authors.affiliation: takuya.hirata@jp.astellas.com
authors.forename: Takuya
authors.initials: T
authors.lastname: Hirata
authors.forename: Toshiyuki
authors.initials: T
authors.lastname: Funatsu
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Keto
authors.forename: Shinobu
authors.initials: S
authors.lastname: Akuzawa
authors.forename: Hiraku
authors.initials: H
authors.lastname: Akiho
authors.forename: Akito
authors.initials: A
authors.lastname: Nishida
authors.forename: Masao
authors.initials: M
authors.lastname: Sasamata
authors.forename: Keiji
authors.initials: K
authors.lastname: Miyata
mesh_terms: D000818:Animals; D001562:Benzimidazoles / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003967:Diarrhea / Q000188:drug therapy* / Q000209:etiology; D004305:Dose-Response Relationship, Drug; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000188:drug therapy* / Q000209:etiology; D016032:Randomized Controlled Trials as Topic; D058831:Serotonin 5-HT3 Receptor Antagonists; D012702:Serotonin Antagonists / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use*; D013315:Stress, Psychological / Q000150:complications
chemical_list: D001562:Benzimidazoles; D058831:Serotonin 5-HT3 Receptor Antagonists; D012702:Serotonin Antagonists; C071315:ramosetron